Submission systemSubmit
Advanced Search
Volume 3 Issue 4
Oct.  2023
Turn off MathJax
Article Contents
Article Navigation >  Frigid Zone Medicine  > 2023  >  3(4): 253-256
Xia Zheng, Lihui Chen, Kaiting Lai, Zhiyong Li. Prostate cryoablation: A mini review[J]. Frigid Zone Medicine, 2023, 3(4): 253-256. doi: 10.2478/fzm-2023-0032
Citation: Xia Zheng, Lihui Chen, Kaiting Lai, Zhiyong Li. Prostate cryoablation: A mini review[J]. Frigid Zone Medicine, 2023, 3(4): 253-256. doi: 10.2478/fzm-2023-0032
shu

Prostate cryoablation: A mini review

doi: 10.2478/fzm-2023-0032
  • 1.

    State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China

  • 2.

    Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

  • 3.

    Department of Head and NeckSurgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

Funds:

the National Natural Science Foundation of China 82203320

More Information
  • Corresponding author: Zhiyong Li, E-mail: lizhiy@sysucc.org.cn
  • Received Date: 2023-10-24
  • Accepted Date: 2023-12-06
    • Available Online: 2023-10-01
    Abstract
  • In recent years, cryotherapy has gained increasing acceptance as a treatment for prostate cancer, offering complementary therapeutic benefits when combined with radical surgery and radiotherapy. Despite the potential for surgical complications, it stands as a safe and viable therapeutic modality. Cryotherapy provides an efficient approach for elderly patients, especially those with compromised physical conditions and individuals experiencing recurrence after initial treatment. It has shown promise in extending survival periods and improving the overall quality of life for these patients. This article aims to comprehensively examine the developmental trajectory, surgical techniques, indications, therapeutic outcomes, and potential complications associated within prostate cancer treatment.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    Feng R M, Zong Y N, Cao S M, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond), 2019; 39(1): 22.
    [2]
    Zhou Z G, Qin J, Song C L, et al. circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis. J Cancer, 2023; 14(13): 2574–2584. doi: 10.7150/jca.86940
    [3]
    Liu X, Yu C, Bi Y, et al. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China. Public Health, 2019; 172: 70–80. doi: 10.1016/j.puhe.2019.04.016
    [4]
    Kongnyuy M, Halpern D M, Kosinski K E, et al. Cryosurgery, an alternative treatment option for organ-confined prostate cancer: Current beliefs and practice patterns of urologists. Int Urol Nephrol, 2017; 49(1): 43–48. doi: 10.1007/s11255-016-1440-7
    [5]
    Onik G M, Cohen J K, Reyes G D, et al. Transrectal ultrasound guided percutaneous radical cryosurgical ablation of the prostate. Cancer, 1993; 72(4): 1291–1299. doi: 10.1002/1097-0142(19930815)72:4<1291::AID-CNCR2820720423>3.0.CO;2-I
    [6]
    Song K D. Percutaneous cryoablation for hepatocellular carcinoma. Clin Mol Hepatol, 2016; 22(4): 509–515. doi: 10.3350/cmh.2016.0079
    [7]
    Langenhuijsen J F, Broers E M, Vergunse H. Cryosurgery for prostate cancer: an update on clinical results of modern cryotechnology. Eur Urol, 2009; 55(1): 76–86. doi: 10.1016/j.eururo.2008.08.063
    [8]
    Chosy S G, Nakada S Y, Lee F T, et al. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol, 1998; 159(4): 1370–1374. doi: 10.1016/S0022-5347(01)63618-8
    [9]
    Ravindranath M H, Wood T F, Soh D, et al. Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments anti-ganglioside IgM. Cryobiology, 2002; 45(1): 10–21. doi: 10.1016/S0011-2240(02)00102-5
    [10]
    Sanda M G, Cadeddu J A, Kirk B Y E, et al. Clinically Localized Prostate Cancer: A UA/ASTRO/SUO Guideline. Part Ⅰ: Risk stratification, shared decision making, and care options. J Urol, 2018; 199(3): 683–690. doi: 10.1016/j.juro.2017.11.095
    [11]
    Mohler J L, Lee R J, Antonarakis E S, et al. Prostate Cancer, version 2, 2018. NCCN clinical practice guidelines.
    [12]
    Lian H, Yan G R, Li N T, et al. Salvage cryotherapy with third generation technology for locally recurrent prostate cancer after radiation therapy. Int Urol Nephrol, 2016; 48(9): 1461–1466. doi: 10.1007/s11255-016-1339-3
    [13]
    Edison E, Tariq Shah T, Ahmed H U. Focal Ablation of Early Stage Prostate Cancer Candidate Selection, Treatment Guidance, and Assessment of Outcome. Urol Clin North Am, 2017; 44(4): 575–585. doi: 10.1016/j.ucl.2017.07.006
    [14]
    Ward J F, Jones J S. Focal cryotherapy for localized pros tate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int, 2012; 109(11): 648–1654.
    [15]
    Li Y H, Elshafei A, Agarwal G, et al. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry. Prostate, 2015; 75(1): 1–7. doi: 10.1002/pros.22881
    [16]
    Valerio M, Cerantola Y, Eggener S E, et al. New and established technology in focal ablation of the prostate: a systematic review. EurUrol, 2017; 71(1): 17–34.
    [17]
    Chen C H, Tsai C Y, Pu Y S. Primary Total Prostate Cryoablation for Localized High-Risk Prostate Cancer: 10-Year Outcomes and Nomograms. Cancers (Basel). 2023; 15(15): 3873. doi: 10.3390/cancers15153873
    [18]
    Bahn D, de Castro Abreu A L, Gill I S, et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol, 2012; 62: 55–63. doi: 10.1016/j.eururo.2012.03.006
    [19]
    Donnelly B J, Saliken J C, Brasher P M, et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer, 2010; 116: 323–330. doi: 10.1002/cncr.24779
    [20]
    Jones J S, Rewcastle J C, Donnelly B J, et al. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol, 2008; 180(2): 554–558. doi: 10.1016/j.juro.2008.04.027
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (309) PDF downloads(4) Cited by()
    Proportional views
    Related

    Contact Us

    Editorial Office: Frigid Zone Medicine, Editorial Office of Frigid Zone Medicine, Heilongjiang Health Development Research Center, Zhongshan Road 112, Xiangfang District, Harbin, 150036, China

    Tel: 0451-87253028

    E-mail: editorialoffice@frigidzonemedicine.com

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    Links

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return